XSHE
002064
Market cap7.24bUSD
Oct 09, Last price
10.20CNY
1D
4.40%
1Q
0.89%
Jan 2017
85.79%
IPO
117.02%
Name
Huafon Chemical Co Ltd
Chart & performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Huafon Chemical Co., Ltd., a Chinese enterprise established in 1999 and based in Ruian, specializes in the manufacturing and distribution of spandex. Its key product is Qianxi spandex yarn, a flexible polyurethane elastic fiber widely incorporated into diverse applications like underwear, swimwear, socks, jeans, casual athletic wear, medical bandages, fabric ribbons, and diapers. In addition to its primary spandex operations, the company also produces cyclohexanone and other benzene-based chemicals. Its business activities extend to the global trade of textile items, notably spandex fibers, and it also engages in the power and heat cogeneration sector. The firm was previously known as Zhejiang Huafeng Spandex Co., Ltd. before adopting its current name in January 2021.
Key people
Feihuang You
Vice Chairman of the Board · since 2018
Jie Sun
Chief Financial Officer, Finance Director · since 2019
Ning Xu
Deputy General Manager · since 2010
Xiaoyin Yang
Deputy General Manager · since 2015
Zhili Yu
Executive Deputy General Manager · since 2021
Suojun Zhang
Deputy General Manager · since 2020
Hyeon Sang Joo
General Manager, Director · since 2021
Yilun Li
Secretary of the Board, Director · since 2020
Yingbin Miao
Director · since 2024
Congdeng Yang
Chairman of the Board · since 2012
Qiwei Ye
Director · since 2020
Independent Director · since 2021
Bin Pan
Independent Director · since 2024
Haitao Song
Independent Director · since 2021
Headquarters & legal address
浙江省温州市瑞安市瑞安经济开发区开发区大道1788号
温州市, ZJ 310000
CN
温州市, ZJ 310000
CN
Valuation
Title CNY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||